日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quantification of the Actin-Binding Protein Flightless-I in Human Serum by Automated Western Blot System and Investigation of Its Diagnostic Potential in Sepsis

利用自动化蛋白质印迹系统定量人血清中肌动蛋白结合蛋白Flightless-I,并研究其在脓毒症诊断中的应用潜力

Szirmay, Balázs; Ragán, Dániel; Huber, Tamás; Bugyi, Beáta; Tóth, Natália; Deres, László; Mühl, Diána; Csontos, Csaba; Halmosi, Róbert; Miseta, Attila; Kőszegi, Tamás; Horváth-Szalai, Zoltán

Prevalence and Cardiopulmonary Characteristics of Post-COVID Syndrome at a Hungarian Tertiary Referral Hospital

匈牙利一家三级转诊医院新冠后遗症的患病率和心肺特征

Fekete, Krisztina; Sándor, Barbara; Kacsó, Anita; Pálfi, Anita; Tóth, Szilard; Deres, László; Szabados, Eszter; Czopf, László; Rábai, Miklós; Gál, Roland; Alexy, Tamas; Habon, Tamás; Tóth, Kálmán; Alizadeh, Hussain; Soós, Szilvia; Halmosi, Róbert

Cardiac effects of OPA1 protein promotion in a transgenic animal model

OPA1 蛋白促进转基因动物模型中的心脏效应

Kitti Bruszt, Orsolya Horvath, Katalin Ordog, Szilard Toth, Kata Juhasz, Eszter Vamos, Katalin Fekete, Ferenc Gallyas, Kalman Toth, Robert Halmosi, Laszlo Deres

Myocarditis after COVID-19 and influenza infections: insights from a large data set

COVID-19 和流感感染后发生心肌炎:来自大型数据集的启示

Magyar, Klara; Halmosi, Robert; Toth, Kalman; Alexy, Tamas

A phase III, multicentre, randomised, investigator-masked, cross-over, comparative, non-inferiority trial evaluating the efficacy and tolerability of generic preservative-free Latanoprost (Polpharma S.A.) compared to Xalatan(®) (Pfizer) in patients with ocular hypertension or primary open-angle glaucoma

一项III期、多中心、随机、研究者设盲、交叉、对照、非劣效性试验,旨在评估不含防腐剂的仿制药拉坦前列素(Polpharma SA)与Xalatan®(辉瑞)在眼高压或原发性开角型青光眼患者中的疗效和耐受性。

Czumbel, Norbert; Acs, Tamas; Bator, Gyorgy; Halmosi, Agnes; Egorov, Evgeniy A; Maltsev, Dmitrii S

Resveratrol and beyond: The Effect of Natural Polyphenols on the Cardiovascular System: A Narrative Review

白藜芦醇及其他:天然多酚对心血管系统的影响:综述

Gál, Roland; Halmosi, Róbert; Gallyas, Ferenc Jr; Tschida, Michael; Mutirangura, Pornthira; Tóth, Kálmán; Alexy, Tamás; Czopf, László

L-arginine, asymmetric and symmetric dimethylarginine for early outcome prediction in unselected cardiac arrest victims: a prospective cohort study

L-精氨酸、不对称二甲基精氨酸和对称二甲基精氨酸用于预测未筛选心脏骤停患者的早期预后:一项前瞻性队列研究

Csiszar, Beata; Marton, Zsolt; Riba, Janos; Csecsei, Peter; Nagy, Lajos; Toth, Kalman; Halmosi, Robert; Sandor, Barbara; Kenyeres, Peter; Molnar, Tihamer

Mitochondrial protective effects of PARP-inhibition in hypertension-induced myocardial remodeling and in stressed cardiomyocytes

PARP 抑制对高血压引起的心肌重塑和应激心肌细胞的线粒体保护作用

K Ordog, O Horvath, K Eros, K Bruszt, Sz Toth, D Kovacs, N Kalman, B Radnai, L Deres, F Gallyas Jr, K Toth, R Halmosi

Modulation of Mitochondrial Quality Control Processes by BGP-15 in Oxidative Stress Scenarios: From Cell Culture to Heart Failure

BGP-15 在氧化应激情况下对线粒体质量控制过程的调节:从细胞培养到心力衰竭

Orsolya Horvath, Katalin Ordog, Kitti Bruszt, Nikoletta Kalman, Dominika Kovacs, Balazs Radnai, Ferenc Gallyas, Kalman Toth, Robert Halmosi, Laszlo Deres

BGP-15 Protects against Heart Failure by Enhanced Mitochondrial Biogenesis and Decreased Fibrotic Remodelling in Spontaneously Hypertensive Rats

BGP-15 通过增强线粒体生物合成和减少自发性高血压大鼠的纤维化重塑来预防心力衰竭

Orsolya Horvath, Katalin Ordog, Kitti Bruszt, Laszlo Deres, Ferenc Gallyas, Balazs Sumegi, Kalman Toth, Robert Halmosi